Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by variants in the MAK gene.
Biomarker and diagnostic research for MAK-related retinopathy has been reported in the published literature.
No clinical trials have been registered for MAK-related retinopathy.
4 publications have been identified in PubMed for MAK-related retinopathy. Research spans Other (25%), Diagnostic / Biomarker (25%), and Review / Meta-Analysis (25%).
Baig A (2025). [PMID: 41291483](https://pubmed.ncbi.nlm.nih.gov/41291483/). *BMC Geriatr*. [Diagnostic / Biomarker]
Quiambao A (2025). [PMID: 40678696](https://pubmed.ncbi.nlm.nih.gov/40678696/). *EClinicalMedicine*. [Other]
Ran J (2025). [PMID: 40433930](https://pubmed.ncbi.nlm.nih.gov/40433930/). *Adv Sci (Weinh)*. [Review / Meta-Analysis]
Zheng R (2025). [PMID: 39848245](https://pubmed.ncbi.nlm.nih.gov/39848245/). *Cell Rep Med*. [Gene Therapy / Novel Therapeutics]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 4:32 PM UTC
Common questions about MAK-related retinopathy